SCHEMBL6168727

SCHEMBL6168727

CC(=O)C(=Cc1ccc(C)cc1)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C1 Q04828 4/20 0.56
MAPT P10636 7/20 0.53
ALDH1A1 P00352 4/20 0.53
HPGD P15428 2/20 0.53
CYP3A4 P08684 1/20 0.53
AKR1C2 P52895 3/20 0.53
NPC1 O15118 3/20 0.53
RAB9A P51151 3/20 0.53
AKR1C3 P42330 2/20 0.53
POLB P06746 2/20 0.53
PTGS2 P35354 2/20 0.51
KMT2A Q03164 5/20 0.50
MEN1 O00255 4/20 0.50
LMNA P02545 3/20 0.50
NPSR1 Q6W5P4 2/20 0.50
CES2 O00748 1/20 0.50
CES1 P23141 1/20 0.50
CRHBP P24387 1/20 0.50
CRHR2 Q13324 1/20 0.50
PLA2G1B P04054 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6168722 1.00 AKR1C1 (0.56) AKR1C1MAPTALDH1A1HPGDCYP3A4
SCHEMBL7992874 0.89 AKR1C1 (0.70) AKR1C1MAPTALDH1A1HPGDCYP3A4
SCHEMBL6172379 0.89 AKR1C1 (0.70) AKR1C1MAPTALDH1A1HPGDCYP3A4
SCHEMBL5183481 0.89 AKR1C1 (0.70) AKR1C1MAPTALDH1A1HPGDCYP3A4
SCHEMBL9125567 0.87 AKR1C1 (0.75) AKR1C1MAPTALDH1A1HPGDCYP3A4
SCHEMBL9125576 0.87 AKR1C1 (0.75) AKR1C1MAPTALDH1A1HPGDCYP3A4
SCHEMBL11019288 0.84 AKR1C1 (0.55) AKR1C1MAPTALDH1A1HPGDCYP3A4
SCHEMBL6170114 0.84 MEN1 (0.62) AKR1C1MAPTALDH1A1HPGDAKR1C2
SCHEMBL6170117 0.84 MEN1 (0.62) AKR1C1MAPTALDH1A1HPGDAKR1C2
SCHEMBL6169411 0.84 ALDH1A1 (0.55) AKR1C1MAPTALDH1A1HPGDCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1528059-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle LLC (US) 2005-05-04 EP disclosed
EP-0809636-B1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2002-09-04 EP disclosed
EP-1223167-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle & Co. (US) 2002-07-17 EP disclosed
US-5859257-A ANTIINFLAMMATORY, ANTIARTHRITIC AGENTS G. D. SEARLE & CO. (US) 1999-01-12 US disclosed
EP-0809636-A1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-12-03 EP disclosed
WO-1996025405-A1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-08-22 WO disclosed